InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by KARBE FRANK, Executive. Director active across 4 companies, notably Myovant Sciences Ltd.. Aggregated, 11 filings have been logged. Breakdown: 4 buys · 2 sells. Total volume traded: €594k. History available since 7 July 2021. The latest transaction was disclosed on 24 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
57,500 shares0Common StockSEC:0001610618-25-000012:0
12,500 shares@ US$7.926728.7% of flowCommon StockSEC:0000950170-24-136391:0
Ideal exit: 9 Sept 2025 (T+270)
25,000 shares@ US$10.164571.3% of flowCommon StockSEC:0000950170-24-067365:0
10,500 shares0Common StockSEC:0000950170-24-064820:0
62,500 shares0Common StockSEC:0000950170-23-071939:0
137,005 shares@ US$0.729924.0% of flowCommon StockSEC:0000950170-23-035680:0
Ideal exit: 22 Apr 2024 (T+270)
9,000 shares0Common StockSEC:0001209191-23-033007:0
242,424 shares@ US$0.82548.4% of flowCommon StockSEC:0000899243-23-011189:0
Ideal exit: 5 Jan 2024 (T+270)
50,000 shares@ US$2.093927.6% of flowCommon StockSEC:0000899243-22-031206:0
Ideal exit: 12 Jun 2023 (T+270)
3,232 shares@ US$21.7550.0% of flowCommon SharesSEC:0001209191-21-046171
3,232 shares@ US$21.7550.0% of flowCommon SharesSEC:0001209191-21-046171:0
11 of 11 declarations
About KARBE FRANK
Frank Karbe is the Principal Financial and Accounting Officer at Myovant Sciences Ltd. In this role, he oversees the financial and accounting operations of the company, contributing to its financial strategy.
